======= BCL9L =======
== Gene Information ==
* **Official Symbol**: BCL9L
* **Official Name**: BCL9 like
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=283149|283149]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q86UU0|Q86UU0]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=BCL9L&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BCL9L|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/609004|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Transcriptional regulator that acts as an activator. Promotes beta-catenin transcriptional activity. Plays a role in tumorigenesis. Enhances the neoplastic transforming activity of CTNNB1 (By similarity). {ECO:0000250}.
|BCL9|
|beta-catenin-TCF complex|
|beta-catenin-TCF complex assembly|
|positive regulation of epithelial to mesenchymal transition|
|skeletal muscle cell differentiation|
|somatic stem cell population maintenance|
|negative regulation of transforming growth factor beta receptor signaling pathway|
|negative regulation of cellular response to transforming growth factor beta stimulus|
|regulation of epithelial to mesenchymal transition|
|beta-catenin binding|
|canonical Wnt signaling pathway|
|regulation of transforming growth factor beta receptor signaling pathway|
|negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|
|regulation of cellular response to transforming growth factor beta stimulus|
|skeletal muscle tissue development|
|skeletal muscle organ development|
|stem cell population maintenance|
|maintenance of cell number|
|negative regulation of cellular response to growth factor stimulus|
|regulation of transmembrane receptor protein serine/threonine kinase signaling pathway|
|regulation of cellular response to growth factor stimulus|
|striated muscle tissue development|
|transcription coactivator activity|
|muscle organ development|
|muscle tissue development|
|Wnt signaling pathway|
|cell-cell signaling by wnt|
|cell surface receptor signaling pathway involved in cell-cell signaling|
|muscle structure development|
|regulation of cell morphogenesis|
|nucleolus|
|positive regulation of cell differentiation|
|regulation of anatomical structure morphogenesis|
|cell-cell signaling|
|positive regulation of transcription by RNA polymerase II|
|negative regulation of signal transduction|
|negative regulation of cell communication|
|negative regulation of signaling|
|positive regulation of developmental process|
|positive regulation of transcription, DNA-templated|
|protein-containing complex assembly|
|negative regulation of response to stimulus|
|positive regulation of nucleic acid-templated transcription|
|positive regulation of RNA biosynthetic process|
|positive regulation of RNA metabolic process|
|positive regulation of multicellular organismal process|
|tissue development|
|regulation of cell differentiation|
|protein-containing complex subunit organization|
|positive regulation of nucleobase-containing compound metabolic process|
|positive regulation of macromolecule biosynthetic process|
|positive regulation of cellular biosynthetic process|
|positive regulation of gene expression|
|positive regulation of biosynthetic process|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp6|Bortezomib 0.005μM R00 exp6]]|-1.73|
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 3/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|1/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4471
* **Expression level (log2 read counts)**: 4.05
{{:chemogenomics:nalm6 dist.png?nolink |}}